Cargando…

Assessment of the Prevalence of Infections in Pediatric Patients With Acute Lymphoblastic Leukemia

Infections cause notable treatment-related morbidity during pediatric acute lymphoblastic leukemia/lymphoma (ALL/LLy) therapy. Infections are the most critical cause of morbidity and mortality in children undergoing treatment for acute lymphoblastic leukemia (ALL). Children with ALL, who are frequen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nair, Arun, Elballushi, Ruaa, Joshi, Riecha, Anjanappa, Sanvithi, Akter, Maksuda, Arif, Sehrish, Rehman, Sana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10636770/ https://www.ncbi.nlm.nih.gov/pubmed/37954717 http://dx.doi.org/10.7759/cureus.46837

Ejemplares similares

Comparison of Pharmacological Therapies in Relapse Rates in Patients With Relapsing-Remitting Multiple Sclerosis
por: Etta, Indu, et al.
Publicado: (2023)

Epigenetic Modifications in Pediatric Acute Lymphoblastic Leukemia
por: Burke, Michael J., et al.
Publicado: (2014)

Review of the Current Knowledge of Reactive Attachment Disorder
por: Irfan, Neha, et al.
Publicado: (2022)

Chemotherapy-Induced Oxidative Stress in Pediatric Acute Lymphoblastic Leukemia
por: Chaudhary, Preety, et al.
Publicado: (2023)

The Role of the Central Nervous System Microenvironment in Pediatric Acute Lymphoblastic Leukemia
por: Gossai, Nathan P., et al.
Publicado: (2017)

Gene Mutations Related to Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia
por: Zhang, JinFang, et al.
Publicado: (2022)

Prevalence of Osteopathologies in Children and Adolescents After Diagnosis of Acute Lymphoblastic Leukemia
por: Schündeln, Michael M., et al.
Publicado: (2020)

Aberrant GATA2 Activation in Pediatric B-Cell Acute Lymphoblastic Leukemia
por: Wang, Han, et al.
Publicado: (2022)

Association of the clinical profile and overall survival of pediatric patients with acute lymphoblastic leukemia
por: Correa, Bruno Terra, et al.
Publicado: (2023)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
por: Maese, Luke, et al.
Publicado: (2022)

Testicular relapse of acute lymphoblastic leukemia()
por: Carolan, Alexandra, et al.
Publicado: (2023)

Targeted Treatment and Immunotherapy in High-risk and Relapsed/Refractory Pediatric Acute Lymphoblastic Leukemia
por: Graiqevci-Uka, Violeta, et al.
Publicado: (2022)

Pediatric Leukemia From an Orthopedic Perspective: A Case of Acute Lymphoblastic Leukemia Initially Managed as Septic Hip With Osteomyelitis
por: Gkoudina, Antigoni, et al.
Publicado: (2022)

The safety of blinatumomab in pediatric patients with acute lymphoblastic leukemia: A systematic review and meta-analysis
por: Marrapodi, Maria Maddalena, et al.
Publicado: (2022)

Synthesized evidence for childhood acute lymphoblastic leukemia
por: Onyije, Felix M., et al.
Publicado: (2023)

Blinatumomab for treating pediatric B-lineage acute lymphoblastic leukemia: A retrospective real-world study
por: Wu, Ying, et al.
Publicado: (2022)

Case Report: Trichosporon japonicum Fungemia in a Pediatric Patient With Refractory Acute B Cell Lymphoblastic Leukemia
por: Albitar-Nehme, Sami, et al.
Publicado: (2022)

Thrombosis Complications in Pediatric Acute Lymphoblastic Leukemia: Risk Factors, Management, and Prevention: Is There Any Role for Pharmacologic Prophylaxis?
por: Rodriguez, Vilmarie
Publicado: (2022)

Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era
por: Mengxuan, Shang, et al.
Publicado: (2022)

Corrigendum: Blinatumomab for treating pediatric B-lineage acute lymphoblastic leukemia: A retrospective real-world study
por: Wu, Ying, et al.
Publicado: (2022)

Impact of microRNA polymorphisms on high-dose methotrexate-related hematological toxicities in pediatric acute lymphoblastic leukemia
por: Zhan, Min, et al.
Publicado: (2023)

Malignant hypercalcemia as the debut of acute lymphoblastic leukemia in a pediatric patient—a diagnostic and therapeutic approach: Case report
por: Bonilla Gonzalez, Carolina, et al.
Publicado: (2022)

Pancytopenia – (?) An obstacle in the diagnosis and outcome of pediatric acute lymphoblastic leukemia
por: Raja, Shruti, et al.
Publicado: (2015)

High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance
por: Chen, Aaron R, et al.
Publicado: (2020)

Bacteriological Spectrum and Antibiotic Susceptibility on Blood Culture in Newly Diagnosed Pediatric Patients With Acute Lymphoblastic Leukemia During the Induction Phase
por: Fawad, Usman
Publicado: (2022)

Perforated jejunitis in a child with acute lymphoblastic leukemia treated with pegaspargase
por: Tang, Elizabeth R., et al.
Publicado: (2018)

Relapsed Childhood Acute Lymphoblastic Leukemia: A Single-Institution Experience
por: Tuong, Pham Nguyen, et al.
Publicado: (2020)

Can CD34(+)CD38(−) lymphoblasts, as likely leukemia stem cells, be a prognostic factor in B-cell precursor acute lymphoblastic leukemia in children?
por: Stolpa, Weronika, et al.
Publicado: (2023)

Effects of TPMT, NUDT15, and ITPA Genetic Variants on 6-Mercaptopurine Toxicity for Pediatric Patients With Acute Lymphoblastic Leukemia in Yunnan of China
por: Mao, Xiaoyan, et al.
Publicado: (2021)

Case Report: The Use of Intravenous SMOFlipid Infusion to Treat Severe Asparaginase-Induced Hypertriglyceridemia in Two Pediatric Acute Lymphoblastic Leukemia Patients
por: Lau, Sie Chong Doris, et al.
Publicado: (2021)

The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)
por: Velasco, Pablo, et al.
Publicado: (2023)

The Role of Adipose Tissue and Obesity in Causing Treatment Resistance of Acute Lymphoblastic Leukemia
por: Sheng, Xia, et al.
Publicado: (2014)

Clinical Features and Risk Factors of Severe Pneumonia in Children With Acute Lymphoblastic Leukemia
por: Liu, Chun-yan, et al.
Publicado: (2022)

Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?
por: Levy, Gabriel, et al.
Publicado: (2022)

Infectious Complications in Paediatric Haematopoetic Cell Transplantation for Acute Lymphoblastic Leukemia: Current Status
por: Zajac-Spychala, Olga, et al.
Publicado: (2022)

Effect of Vertebral Fracture on Auxological Profiles of Children Undergoing Acute Lymphoblastic Leukemia Treatment
por: Ahn, Moon Bae, et al.
Publicado: (2021)

Supportive methods for childhood acute lymphoblastic leukemia then and now: A compilation for clinical practice
por: Podpeskar, Alexandra, et al.
Publicado: (2022)

Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children
por: Xie, Jiao, et al.
Publicado: (2023)

Polyneuropathy in Acute Lymphoblastic Leukemia Long-Term Survivors: Clinical and Electrophysiological Characteristics With the Impact of Radiotherapy
por: Kroczka, Slawomir, et al.
Publicado: (2021)

Comparison of Five-Year Survival Rate Between Black and White Children With Acute Lymphoblastic Leukemia
por: Bryant, Courtney, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ft8phela3unuu6jit3r1erp0vj